To explore the impact of impeding tumor competition for cystine on T cell anti-tumor immunity, we generated Slc7a11 knockdown (KD) B16F10 cells (Fig. 3a and Supplementary Fig. 3a). Here, SLC7A11 is linked to neoplasm.